Related Experiment Video
Updated: Sep 22, 2025

Multifocal Electroretinograms
Published on: December 4, 2011
Bilateral multifocal central serous retinopathy following mRNA COVID-19 vaccine
N Mechleb1, Z Khoueir2, A Assi3
1Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon; Beirut Eye and ENT Specialist Hospital, Beirut, Lebanon.
Abstract:
We present a case of acute bilateral multifocal CSCR in a young healthy Caucasian female occurring 3 days after receiving the first dose of the Pfizer-BioNTech BNT162b2 COVID-19 mRNA vaccine. The true incidence of this adverse reaction might be underreported in asymptomatic unilateral or paracentral cases. We believe that the post-COVID-19 vaccination occurrence of CSCR is not a sufficient reason to withhold the second dose of the vaccine. Further studies are required to ascertain the best way to prevent and manage this complication.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

